NL-OMON23581CompletedNot Applicable
Bronchoscopic Lung Volume Reduction with endobronchial valves using best responder criteria in patients with severe COPD - The STELVIO trial.
MC-Groningen, Pulmonary diseases0 sites68 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 68
Study Overview
Brief Summary
/A
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Patient > 35 years of age;
- •2. CT scan indicates heterogeneous emphysema (>25% difference in destruction score between ipsilateral lobes);
Exclusion Criteria
- •1. Hypercapnia defined by PaCO2>8.0 kPa, or hypoxemia defined by PaO2<6.0kPa, both measured on room air;
- •2. 6MWT <140 meters;
Investigators
Similar Trials
Completed
Phase 3
Bronchoscopic Lung Volume reduction with endobronchial valves using best responder criteria in patients with severe COPDCOPD Emphysema10038716NL-OMON39131niversitair Medisch Centrum Groningen68
Completed
Not Applicable
Bronchoscopic lung volume reduction for patients with emphysemaCOPD - heterogeneous emphysemaRespiratoryEmphysemaISRCTN04761234Imperial College London (UK)50
Completed
Phase 2
Low Cost Biological Lung Volume Reduction Therapy for Advanced EmphysemaPulmonary EmphysemaNCT02107209Mansoura University15
Recruiting
Not Applicable
interventional pulmonologyRespiratoryPACTR201602001308660Mansoura university hospital
Recruiting
Not Applicable
Bronchoscopic EmphysemA Treatment in THE NetherLandsCOPDNCT02815683University Medical Center Groningen500